Free shipping on all orders over $ 500

Antineoplaston A10

Cat. No. M20741
Antineoplaston A10 Structure
Size Price Availability
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Antineoplaston A10 is a naturally occurring substance in the human body that that can be potentially used for the treatment of glioma, lymphoma, astrocytoma and breast cancer. The main ingredient active of antineoplaston A10 (Phenylacetylglutamine, PG) inhibits RAS and promotes apoptosis.

Chemical Information
Molecular Weight 246.26
Formula C13H14N2O3
CAS Number 91531-30-5
Solubility (25°C) DMSO 49 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Suqin Duan, et al. Virol Sin. Pathogenic analysis of coxsackievirus A10 in rhesus macaques

[2] PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Antineoplastons (PDQ®): Patient Version

[3] Xian-Jun Qu, et al. Anticancer Res. Induction of apoptosis in human hepatocellular carcinoma cells by synthetic antineoplaston A10

[4] Stanislaw R Burzynski, et al. Drugs R D. Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report

[5] H Tsuda, et al. Kurume Med J. Inhibitory effect of antineoplaston A10 and AS2-1 on human hepatocellular carcinoma

Related Ras Products
BI-0474

BI-0474 is a covalent KRASG12C inhibitor. The IC50 value for GDP-KRAS::SOS1 protein-protein interaction was 7.0 nM. BI-0474 also showed better antitumor activity in non-small cell lung cancer xenograft models.

MRTX849 acid

MRTX849 acid can be used to synthesize PROTAC LC-2. LC-2 is a potent, first-in-class PROTAC capable of degrading endogenous KRAS G12C (DC50, between 0.25 and 0.76 μM).

BDP9066

BDP9066 is a potent and selective MRCK inhibitor, reducing substrate phosphorylation.

ASP2453

ASP2453 is a potent, selective and covalent inhibitor of KRAS G12C. ASP2453 inhibits Son of Sevenless (SOS)-mediated interactions between KRAS G12C and Raf with an IC50 value of 40 nM.

AZD4625

AZD4625 is a highly potent, selective, covalent and metabotropic inhibitor of the mutant GTPase KRASG12C. AZD4625 has high oral bioavailability. It is being developed to study advanced solid malignancies.

  Catalog
Abmole Inhibitor Catalog




Keywords: Antineoplaston A10 supplier, Ras, inhibitors, activators

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.